So if we still have Rupert, then just before you leave, I wanted to ask you, given you are coming in from the outside and Bristol has a vast array of next-generation immuno-oncology targets, both internally discovered as well as brought into the company through business developments, and there’s bempeg IL-2, there’s IL-8, there’s CCR2, CCR5, various couple of CTLA-4 modifications.
Refer to the input text as context and select the correct relationship between 'array' and 'company' from the available options.
Options: headquarters location, industry, legal form, developer